tiprankstipranks
Trending News
More News >

Consun Pharmaceutical Group Updates Nomination Committee for Enhanced Governance

Story Highlights
Consun Pharmaceutical Group Updates Nomination Committee for Enhanced Governance

Elevate Your Investing Strategy:

An update from Consun Pharmaceutical Group Ltd. ( (HK:1681) ) is now available.

Consun Pharmaceutical Group Ltd. announced changes in its Nomination Committee, effective June 20, 2025, with Mr. An Meng stepping down and Dr. Zhang Lihua joining as a member. This change aligns with the updated Corporate Governance Code and aims to enhance the company’s governance practices, thereby potentially improving its overall performance and diversity.

The most recent analyst rating on (HK:1681) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on Consun Pharmaceutical Group Ltd. stock, see the HK:1681 Stock Forecast page.

More about Consun Pharmaceutical Group Ltd.

Consun Pharmaceutical Group Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development, manufacturing, and sale of pharmaceutical products.

Average Trading Volume: 2,346,318

Technical Sentiment Signal: Buy

Current Market Cap: HK$9.36B

For a thorough assessment of 1681 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1